Luo et al. found that dulaglutide inhibits HG-induced endothelial dysfunction via SIRT1-dependent inhibition of NLRP3 inflammasome activation and expression of NOX4 and TXNIP99. The gene discussed is NOX4; the disease is endothelial dysfunction.